Commission Regulation amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benzovindiflupyr, chlorantraniliprole, emamectin, quinclorac, spiromesifen, and triflumuron in or on certain products (2024/2630(RPS)) | EuroLens